Education vital to help patients explore gene therapies for blindness: Australian study
Therapeutics | News | 0 Comment | 07 Oct, 2022
Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat ...Read more
Hong Kong develops novel RNA nanoparticle for atherosclerosis treatment
Therapeutics | News | 0 Comment | 06 Oct, 2022
A team of researchers at The Chinese University of Hong Kong (CUHK) has developed a novel RNA nanoparticle to offer a po...Read more
Singapore pumps in SGD19.2 M for novel liver cancer treatment trial
Therapeutics | News | 1 Comment | 06 Oct, 2022
A multi-national, investigator-initiated and industry-backed clinical trial has been launched to test the efficacy of a ...Read more
MRFF backs Monash health and medical research with $28M in funding
Therapeutics | News | 0 Comment | 30 Sep, 2022
The Australian Government’s Medical Research Future Fund (MRFF) has invested $28 million in funding for Monash res...Read more
New Zealand opens doorways for better diabetic heart health
Therapeutics | News | 0 Comment | 30 Sep, 2022
Dr June-Chiew Han and fellow researchers from Waipapa Taumata Rau University of Auckland, New Zealand are looking closel...Read more
First Southeast Asian study to advance pulmonary hypertension early detection
Therapeutics | News | 0 Comment | 30 Sep, 2022
MiRXES Pte Ltd, a Singapore-headquartered biotechnology company, has collaborated with National University Hea...Read more
Biosyngen boosts cell therapy GMP capabilities in Singapore
Therapeutics | News | 0 Comment | 28 Sep, 2022
Singapore-based startup Biosyngen has signed to set up a cell therapy GMP facility which will serve as a base to develop...Read more
Australia developing new tools to improve diagnosis, treatment of blood cancer
Therapeutics | News | 0 Comment | 27 Sep, 2022
Australian scientists will use new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24...Read more
Cynata Therapeutics gets $1 M grant to develop heart disease treatment
Therapeutics | News | 0 Comment | 28 Sep, 2022
Cynata Therapeutics has announced that the Australian Government National Health and Medical Research Council (NHMRC) ha...Read more
Singapore awards NRF grant to develop novel therapies for liver cancer
Therapeutics | News | 0 Comment | 21 Sep, 2022
A team of multidisciplinary scientists has been awarded the prestigious National Research Foundation (NRF) Singapo...Read more
Singapore identifies role of 'harmless' bacteria in worsening lung diseases
Therapeutics | News | 0 Comment | 20 Sep, 2022
A team of international scientists led by the Nanyang Technological University, Singapore (NTU Singapore) has discovered...Read more
Australia's EpiAxis Therapeutics partners with University Health Newtork to study prostate cancer
Therapeutics | News | 0 Comment | 20 Sep, 2022
Australian firm EpiAxis Therapeutics, a leading epigenetics company with a focus on cancer treatment and prevention recu...Read more
Singapore opens Centre for Microbiome Medicine to improve human health
Therapeutics | News | 0 Comment | 15 Sep, 2022
Nanyang Technological University, Singapore (NTU Singapore) has launched the Centre for Microbiome Medici...Read more
Korea establishes novel strategy to tackle Huntington’s disease
Therapeutics | News | 0 Comment | 13 Sep, 2022
Through an international joint research effort involving ProQR Therapeutics of the Netherlands, Université Grenob...Read more
Stem cells could be key to slowing ageing process: New Zealand study
Therapeutics | News | 0 Comment | 08 Sep, 2022
A “serendipitous finding” by a team of researchers at the University of Auckland, New Zealand could shed lig...Read more
Therapeutics | News | 0 Comment | 08 Sep, 2022
The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...Read more
Singapore sets up world's first integrated pre-clinical & clinical ageing research institute
Therapeutics | News | 0 Comment | 07 Sep, 2022
The National University Health System (NUHS) has established the NUHS Centre for Healthy Longevity &...Read more
Australian startup OccuRx secures $16 M to progress therapies for inflammation, fibrosis
Therapeutics | News | 0 Comment | 07 Sep, 2022
Australian biotech startup OccuRx has announcesd a $16 million cash injection to progress into clinical phase studies fo...Read more